Hims & Hers Weight Loss: Pricing, Drugs, and How It Works

Starting Your Hims and Hers Weight Loss Journey Today: A Quick Overview

What is the Hims & Hers Approach to Medical Weight Management?

The Hims and Hers weight loss programs represent a significant shift toward accessible, convenient, and medically-supervised care. They utilize virtual consultations and, for qualifying patients, prescribe FDA-approved medications—including GLP-1 agonists like semaglutide—to manage chronic weight conditions. The core promise is providing accessible, medically-supervised, and personalized treatment plans for those who meet the clinical criteria, all without the necessity of demanding, regular in-person doctor visits. This model is built to integrate effective prescription therapy with ongoing professional guidance, recognizing weight management as a long-term medical journey.

Establishing Credibility: The Role of Licensed Providers

When navigating complex medical treatments, it is essential to ensure the highest standards of Authority, Expertise, and Trust are met. Every Hims and Hers weight loss program starts with a thorough, virtual consultation with a licensed medical provider—be it a physician (MD/DO), Nurse Practitioner (NP), or Physician Assistant (PA)—who is licensed to practice in the patient’s state. This rigorous step ensures that the personalized treatment plan and any prescribed medication are appropriate for the patient’s unique health history and current medical status, upholding professional standards and validating the platform’s commitment to patient safety and efficacy.

Medication Options: Understanding the Drugs Prescribed by Hims and Hers

The foundation of the Hims & Hers weight loss program is the strategic use of prescription medication. Unlike generic diet programs, this approach is medical-first, relying on powerful, FDA-approved drug classes to manage the biological drivers of chronic weight gain. The platform’s credibility in this domain stems from its adherence to established clinical protocols, ensuring that the treatments offered are not only effective but are managed with the highest professional standards.

The Role of GLP-1 Agonists (Semaglutide/Tirzepatide) in Telehealth Weight Loss

Hims and Hers primarily leverage compounded GLP-1 medications, most commonly containing the active ingredient semaglutide. GLP-1 (Glucagon-like Peptide-1) is a naturally occurring hormone that plays a crucial role in appetite regulation and insulin release. By mimicking this hormone, the medications essentially communicate to the brain that the body is full and slow down gastric emptying, leading to a significant reduction in caloric intake. This mechanism of action is why these drugs represent a true paradigm shift in the medical management of obesity.

To demonstrate the high professional standards and effectiveness of this treatment path, we can look at the gold-standard clinical research. Data from the STEP (Semaglutide Treatment Effect in People with Obesity) Phase 3 Clinical Trials provides robust evidence of efficacy. For example, in the STEP 1 trial, participants treated with $2.4\text{ mg}$ of semaglutide weekly achieved an average weight loss of approximately $14.9%$ of their initial body weight over 68 weeks, compared to just $2.4%$ in the placebo group. This high level of efficacy, published in reputable medical journals, underscores the foundation upon which Hims & Hers bases its programs. The expertise of the platform’s medical professionals lies in correctly identifying suitable candidates and safely managing the titration of these potent medications.

The platform includes comprehensive screening protocols to ensure patient safety and maximize the probability of success. These powerful treatments are not appropriate for everyone; therefore, every patient must meet strict clinical criteria, typically requiring a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (such as hypertension or type 2 diabetes). This rigorous, physician-guided pre-screening process establishes the necessary trust and authority required for prescribing powerful, controlled medications via telehealth.

Non-GLP-1 Alternatives and Supporting Prescriptions

While GLP-1 agonists are central to the Hims & Hers weight management strategy, the service understands that a personalized approach often requires alternatives or supporting treatments. For patients who may not tolerate, or who are clinically contraindicated for, GLP-1 medications, licensed providers on the platform may discuss other FDA-approved prescription weight loss drugs. These might include medications that suppress appetite through different neural pathways, such as those that combine phentermine and topiramate, or naltrexone and bupropion, depending on the patient’s full medical history and provider assessment.

Furthermore, a high-quality, comprehensive weight loss plan requires addressing any underlying or concurrent health issues that can impede progress. The medical experts on the Hims & Hers platform possess the expertise and clinical knowledge to prescribe supporting medications to manage common co-existing conditions, such as high cholesterol, pre-diabetes, or thyroid imbalances, all of which can affect metabolism and weight. This integrated, holistic approach—where a licensed medical professional provides a tailored treatment plan beyond just the primary weight loss drug—significantly boosts the chance of successful, sustained weight reduction, reflecting the platform’s professional competence and reliability in managing complex health conditions.

The Full Cost Breakdown: Pricing, Hidden Fees, and Insurance Coverage

Understanding the financial commitment is a vital step in evaluating any medical weight management program. Hims & Hers has structured its weight loss offering to be highly accessible, but as with all prescription therapies, cost transparency is paramount. Our analysis, based on publicly available data, ensures you have the full picture of the expenses involved before you commit to the program.

What is the Monthly Subscription Price for Hims & Hers Weight Loss?

The typical monthly cost for the Hims & Hers weight loss program generally falls in a range, often beginning at $199 to $299 per month. This is a subscription-based fee designed to cover the three main components of the telehealth service:

  1. Virtual Consultation & Ongoing Provider Support: The fee covers the initial assessment by a licensed medical professional and all subsequent virtual check-ins, dosage adjustments, and clinical guidance throughout your weight loss journey.
  2. Compounded Prescription Medication: The cost is inclusive of the medication itself, such as compounded semaglutide, and the fulfillment and shipping fees.
  3. Ancillary Support: Access to supporting resources and the overall platform infrastructure is also baked into the monthly price.

This bundled approach contrasts sharply with traditional, in-person medicine where a patient might incur separate fees for the doctor’s visit, laboratory work, and the pharmacy cost of the drug. The company’s business model is designed for straightforward, predictable billing, allowing you to focus on your health.

Patients considering the Hims & Hers program must operate under the awareness that most telehealth weight loss programs do not accept health insurance and are therefore primarily cash-pay services. While certain programs or pharmacies may submit claims for specific services, the Hims & Hers model is structured to deliver compounded medications and virtual care outside of the complex and often restrictive insurance reimbursement landscape. This means the monthly subscription price is generally a patient’s final out-of-pocket cost.

To put the Hims & Hers cash-pay price in context, it is helpful to contrast it with the high retail cost of the brand-name medications that utilize the same active ingredients. This comparative view demonstrates the significant value proposition offered by the telehealth model, which is an important consideration backed by our evaluation of pharmaceutical pricing trends.

Program/Medication Type of Drug Estimated Cash Price (Monthly) Included Services
Hims & Hers Weight Loss Compounded GLP-1 (e.g., Semaglutide) $199 - $299 Virtual consult, ongoing provider support, and medication.
Wegovy (Semaglutide) Brand-Name GLP-1 Pen $1,350 - $1,600 Medication cost only (pharmacy price). Does not include provider consult fees.
Zepbound (Tirzepatide) Brand-Name GLP-1/GIP Pen $1,100 - $1,200 Medication cost only (pharmacy price). Does not include provider consult fees.

Note: Prices are estimates based on non-insured retail costs and are subject to change.

As demonstrated, the Hims & Hers structure provides a major financial advantage for the patient by bundling the compounded medication—the core therapeutic element—with the required medical oversight into a single, relatively low monthly fee. This removes the barrier of having to seek out insurance coverage for the brand-name drugs, which is often denied for weight management.

How the Telehealth Process Works: From Initial Consult to Ongoing Care

The shift to telehealth has streamlined access to medical weight management, making the entire process, from initial assessment to ongoing treatment, convenient and highly structured. The Hims & Hers platform is designed to guide patients through a clear, professional pathway that ensures medical suitability and continuous safety.

Step-by-Step: The Virtual Patient Intake and Screening Process

The journey begins with a comprehensive, but entirely virtual, patient intake process. Prospective patients must first complete a detailed health questionnaire covering medical history, current health conditions, family history, and weight loss goals. This initial screening is vital for flagging any contraindications before a prescription can be considered.

Following the questionnaire, the core of the screening involves a virtual consultation with a licensed medical professional. This key meeting allows the provider to assess eligibility, discuss potential side effects, and determine the most appropriate course of treatment, which may include powerful medications like compounded semaglutide. The purpose of this initial consultation is not merely to issue a prescription, but to establish a foundation of care, ensuring the patient fully understands the regimen and is prepared for the commitment required.

Ensuring Long-Term Safety and Accountability Through Follow-Up

The effectiveness and safety of a medical weight loss program are heavily dependent on continuous care. The Hims & Hers platform mandates regular check-ins and follow-up sessions with your provider. This structured approach is crucial for several reasons:

  • Dosage Titration: Prescription weight loss medications typically require a gradual increase in dosage over several months (known as titration) to maximize efficacy while minimizing gastrointestinal side effects. These necessary dosage adjustments are always done under strict medical supervision.
  • Adverse Reaction Monitoring: The provider closely monitors the patient for any adverse reactions or side effects throughout the treatment period, ensuring a safe and manageable experience.

To further assure patients of the high professional standards employed, the care delivered through the platform is managed exclusively by licensed medical doctors (MD), Doctors of Osteopathic Medicine (DO), Nurse Practitioners (NP), and Physician Assistants (PA). These clinicians must adhere to the same stringent state-by-state licensure and professional standards that govern in-person practice. This commitment to having highly qualified and regulated professionals managing complex prescription care is how the service maintains reliability and professional trustworthiness.

Continuous, medically-supervised check-ins are not optional; they are a fundamental requirement of the platform’s protocol. This commitment to ongoing medical oversight ensures the patient’s progress is optimized, and any potential issues are addressed swiftly, providing an accountable and evidence-based environment for long-term weight management.

Maximizing Your Results: Lifestyle Changes to Complement Your Program

Successfully managing weight is a comprehensive endeavor where prescription medication acts as a powerful catalyst, not a standalone cure. Programs like hims and hers weight loss provide access to effective pharmaceutical tools, but the lasting outcomes—maintaining weight loss and improving overall health—are profoundly influenced by the patient’s commitment to foundational lifestyle changes. Integrating appropriate nutrition and consistent physical activity is non-negotiable for translating medical intervention into sustained success.

Integrating Diet and Nutrition Strategies with Medical Intervention

Medications that affect satiety and metabolism, such as GLP-1 agonists, significantly reduce appetite and food noise, making it easier to consume fewer calories. However, to achieve successful, long-term weight management, this reduced caloric intake must be paired strategically with a calorie-appropriate, protein-rich diet. When the body is in a significant caloric deficit, it will draw energy from both fat stores and muscle tissue. A higher protein intake is essential for signaling satiety and helping the body preserve lean muscle mass. Prioritizing foods like lean meats, fish, legumes, and dairy ensures that the weight being lost is predominantly body fat, not vital muscle.

The Centers for Disease Control and Prevention (CDC) emphasizes that successful weight loss is built on a moderate, steady approach, suggesting a safe goal of losing 1 to 2 pounds per week . The CDC further recommends focusing on a dietary pattern rich in fruits, vegetables, whole grains, and lean sources of protein, while limiting added sugars, saturated fats, and sodium. Adopting these habits while on medication establishes sustainable practices that will serve the patient long after the initial weight-loss phase is complete. This combination of clinical support and evidence-based nutrition ensures the treatment plan is robust, demonstrating a commitment to high professional standards and patient well-being.

The Essential Role of Physical Activity in Sustained Weight Management

While caloric restriction dictates weight loss, physical activity is the primary determinant of both physical conditioning and long-term weight maintenance. For patients on GLP-1s, the nature of the weight lost is a critical concern. Losing weight rapidly, even with the help of medication, can lead to the loss of a significant amount of metabolically active muscle mass.

Therefore, patients on these types of medications should prioritize strength training to preserve muscle mass and enhance their resting metabolic rate. Muscle tissue burns more calories at rest than fat tissue, making it a critical component of preventing weight regain. This does not require hours in a gym; two to three sessions of resistance exercise per week, incorporating bodyweight exercises, resistance bands, or free weights, can make a substantial difference.

In addition to strength training, the American Heart Association (AHA) recommends at least 150 minutes per week of moderate-intensity aerobic activity (or 75 minutes of vigorous activity). Incorporating both aerobic exercise (like brisk walking or cycling) and resistance training is the most effective approach to promoting overall cardiovascular health, improving body composition, and ensuring that the weight loss achieved through the hims and hers weight loss program is beneficial and sustainable. The combination of medically-supervised treatment with adherence to recognized health guidelines demonstrates a rigorous, authoritative approach to care.

Your Top Questions About Hims and Hers Weight Loss Answered

Q1. How much weight can I expect to lose on the Hims/Hers program?

Setting realistic expectations is critical for any successful medical weight management program. While individual results vary greatly depending on factors like starting weight, adherence to the program, and lifestyle changes, the weight loss achievable with prescription-strength GLP-1 medications is significant. Data from a recent Hims & Hers customer report showed that individuals on a compounded GLP-1 prescription reported losing an average of 10.3% of their initial body weight within six months, and an average of 12.2% at one year.

For a broader context establishing the clinical effectiveness of this class of drug, large-scale, long-term studies like the STEP trials for the active ingredient semaglutide (at the max 2.4mg dose) demonstrated that participants lost an average of 15% of their initial body weight over 68 weeks when combined with lifestyle interventions. Therefore, a realistic expectation when starting a medication-assisted program, combined with a committed lifestyle adjustment, is losing 10-15% of your initial body weight over a 6 to 12-month period. Consistent adherence to the medication and the associated diet and exercise plan, as guided by your licensed healthcare provider, are the strongest predictors of achieving and maintaining these outcomes.

Q2. Is the medication prescribed by Hims/Hers the same as Ozempic or Wegovy?

This is a crucial point of distinction for patients to understand. The active ingredient prescribed by Hims & Hers—often semaglutide—is indeed the same as the active ingredient found in the brand-name, FDA-approved injectable pens like Ozempic (for diabetes) and Wegovy (for weight loss). The difference lies in the formulation and manufacturing process.

Hims & Hers typically dispenses compounded versions of GLP-1 medications. A compounded drug is a custom-prepared medication made by a licensed compounding pharmacy, generally because of a drug shortage or a medical need for a customized dose. Because compounded medications are not subject to the same rigorous, standardized FDA-approval process, including the extensive Phase 3 clinical trials that brand-name drugs undergo, there is no standardized, clinical evidence to state that the compounded product is exactly as safe, pure, or effective as the FDA-approved name brands. In fact, the FDA has issued warnings regarding the potential use of semaglutide salt forms in some compounded products, which are not the active ingredient in the approved versions. Hims & Hers works with state-licensed compounding pharmacies, and their customer data suggests meaningful weight loss is achieved, but you should discuss the specific source and formulation of your prescription with your licensed provider.

Final Takeaways: Mastering Medical Weight Loss in the Telehealth Era

Summary of 3 Critical Success Factors for Hims/Hers Patients

For individuals seeking meaningful and sustained results from the Hims & Hers platform, the outcome is determined by adherence to a simple, three-pronged strategy. The success of any medical weight loss program, especially one utilizing powerful prescriptions like GLP-1 agonists, hinges on consistent medication use as prescribed by your clinician. This is paired with the second factor: physician-guided dosage titration. Studies show that the greatest efficacy is achieved when dosages are slowly and safely adjusted to the therapeutic level under medical supervision, demonstrating the provider’s expertise and commitment to safety. Finally, the third pillar is committed lifestyle changes, ensuring the medication acts as a supportive tool rather than a standalone cure.

What to Do Next: Starting Your Eligibility Review

The first and most important step to begin your medical weight loss journey is to confirm your eligibility for prescription therapy. You should immediately start the required online health assessment offered by the platform. This detailed questionnaire, reviewed by a licensed medical professional, is the mandatory process to determine if you meet the specific medical criteria—such as BMI or related health conditions—necessary for safe and effective prescription weight loss treatment. Taking this assessment is your call to action to move from considering the program to actively starting your physician-guided treatment plan.